dr.roh
Forum Guru
Topics: 159
Posts: 361
|
< 35 y.o. and breast mass-----1st FNA
> 35 y.o. and breast mass----1st mammogram
----------------------------------------------------------
Is that correct??
|
| peraspera
Forum Elite
Topics: 38
Posts: 233
|
Current mammography screening guidelines by the American Cancer Society include a mammogram every year starting at age 40 & continuing for as long as a woman is in good health.There is no upper age limit at which mammogram screening is no longer indicated.
Women with a strong family history of breast cancer( mother, sister) should begin mammogram screening 5 years earlier than the age at which the youngest family member was when diagnosed with breast cancer.
Any concerning palpable mass or abnormality seen on radiologic imaging should be biopsied to obtain a pathologic diagnosis.
Needle aspiration for palpable cystic lesions.
Fine-needle aspiration biopsy for palpable solid mass.
Excisional biopsy is performed if the FNA does not obtain fluid or tissue or if the mass turns out to be solid & also if citology is nondiagnostic
|
| dr.roh
Forum Guru
Topics: 159
Posts: 361
|
ok still confused 
Now a patient comes in ....doc feels a mass......so age doesnt matter---1st mammogram
2nd FNA---for path report
|
| peraspera
Forum Elite
Topics: 38
Posts: 233
|
http://www.emedicine.com/med/topic3287.htm
|
| MAGY17
Forum Elite
Topics: 30
Posts: 234
|
< 35 years, nofamily history, movable, fluctuant and zise change w/cicle>>>>>>>>>>do FNA
> 35, family history, firm, rigid, axillary adenopathy and skin changes>>>>>>>>>>>do MAMMOGRAPHY OR CORE / EXCISIONAL BIOPSY
DR. ROG YOU`RE RIGH
|
| MAGY17
Forum Elite
Topics: 30
Posts: 234
|
PERASPERA this link said
-annual scrrening mammography with clinical exam age 40 years (this setting os not screening yet)
-mammography is considered inappropiate in pcte younger than 35 y. however, many center are now using mammography in pcte aged 30 y. and older who are in high-risk groups.
|
| dr.roh
Forum Guru
Topics: 159
Posts: 361
|
thanx
|
|
| |
| | | | | | | |
